1. Home
  2. FOLD vs SHOO Comparison

FOLD vs SHOO Comparison

Compare FOLD & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • SHOO
  • Stock Information
  • Founded
  • FOLD 2002
  • SHOO 1990
  • Country
  • FOLD United States
  • SHOO United States
  • Employees
  • FOLD N/A
  • SHOO N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • SHOO Shoe Manufacturing
  • Sector
  • FOLD Health Care
  • SHOO Consumer Discretionary
  • Exchange
  • FOLD Nasdaq
  • SHOO Nasdaq
  • Market Cap
  • FOLD 2.9B
  • SHOO 2.8B
  • IPO Year
  • FOLD 2007
  • SHOO 1993
  • Fundamental
  • Price
  • FOLD $6.83
  • SHOO $19.90
  • Analyst Decision
  • FOLD Strong Buy
  • SHOO Hold
  • Analyst Count
  • FOLD 9
  • SHOO 6
  • Target Price
  • FOLD $17.00
  • SHOO $37.20
  • AVG Volume (30 Days)
  • FOLD 3.9M
  • SHOO 2.4M
  • Earning Date
  • FOLD 05-08-2025
  • SHOO 04-30-2025
  • Dividend Yield
  • FOLD N/A
  • SHOO 4.30%
  • EPS Growth
  • FOLD N/A
  • SHOO 2.17
  • EPS
  • FOLD N/A
  • SHOO 2.35
  • Revenue
  • FOLD $528,294,999.00
  • SHOO $2,282,927,000.00
  • Revenue This Year
  • FOLD $21.83
  • SHOO $19.85
  • Revenue Next Year
  • FOLD $22.16
  • SHOO $8.48
  • P/E Ratio
  • FOLD N/A
  • SHOO $8.47
  • Revenue Growth
  • FOLD 32.29
  • SHOO 15.21
  • 52 Week Low
  • FOLD $6.20
  • SHOO $19.05
  • 52 Week High
  • FOLD $12.65
  • SHOO $50.01
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 32.01
  • SHOO 30.46
  • Support Level
  • FOLD $6.20
  • SHOO $19.41
  • Resistance Level
  • FOLD $6.95
  • SHOO $21.61
  • Average True Range (ATR)
  • FOLD 0.43
  • SHOO 1.66
  • MACD
  • FOLD -0.04
  • SHOO -0.13
  • Stochastic Oscillator
  • FOLD 29.86
  • SHOO 9.04

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About SHOO Steven Madden Ltd.

Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its own stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.

Share on Social Networks: